Drug Database
Back to search

Poland· PL-100369848

Alprolix

A coagulation factor ix product containing eftrenonacogum alpha, registered in Poland by Swedish Orphan Biovitrum AB. The same ATC class is registered in 12 of our 19 countries.

ATC B02BD04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAlprolixATCB02BD04REGISTER NO.PL-100369848PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eftrenonacogum alphaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix is registered in 12 of 19 countries.

Countries holding a registration under ATC B02BD04 (coagulation factor ix), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search coagulation factor ix products by name

Coagulation factor ix · ATC B02BD04

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Eftrenonacogum alpha
Manufacturer
Swedish Orphan Biovitrum AB
Country
Poland (PL)
ATC code
B02BD04
ATC class
Coagulation factor IX
Defined daily dose
600 E, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991273897
  • gtin
    07350031441659

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix against other medicinesHow interaction checks work

Coagulation factor ix · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Coagulation factor ix in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All coagulation factor ix products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Alprolix
  • Liechtenstein · Alprolix
  • Norway · Alprolix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e01b555c-ac60-45d8-a51e-ccd06c6d7c38
GET /v1/drugs/e01b555c-ac60-45d8-a51e-ccd06c6d7c38?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "250 IU",
  "packaging": "05909991273897 ¦ Rpz ¦ Skasowane ¦ EU/1/16/1098/001 ¦ 115469\n1 fiol.  proszku + 1 amp.-strzyk. rozp. 5 ml + zestaw do podawania\n07350031441659 ¦ Rpz ¦ EU/1/16/1098/001 ¦ 128868\n1 fiol. 250 j.m. proszku + 1 amp.-strzyk. rozp. 5 ml + zestaw do podawania ¦ 1 amp.-strzyk. 5 ml",
  "substance": "Eftrenonacogum alpha 250 IU",
  "common_name": "Eftrenonacogum alpha",
  "pl_product_id": "100369848",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about coagulation factor ix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console